Report banner
Home
Industries
Healthcare
Pharmaceutical
report thumbnailEquine Health Market

Equine Health Market Analysis 2024 and Forecasts 2032: Unveiling Growth Opportunities

Equine Health Market by Product (Drug Class, {Anti-Infective, Anti-Inflammatory, Parasiticides, Others}, Vaccines {Inactivated, Live Attenuated, Recombinant, Others}, Supplemental Feed Additives), by Disease Type (West Nile Virus, Equine Rabies, Equine Influenza, Equine Herpes Virus, Potomac Horse Fever, Tetanus, Others), by Distribution Channel (Veterinary Hospitals And Clinics, Retail Pharmacies, Drug Stores, Others), by By Product (Drug Class), by Europe (Germany, U.K., France, Italy, Spain, Scandinavia, Rest of Europe), by Asia Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific), by Latin America (Brazil, Mexico, Rest of Latin America), by Middle East & Africa (GCC, South Africa, Rest of the Middle East & Africa) Forecast 2024-2032

Jun 25 2024
Base Year: 2023
150 Pages
Market Research Future Logo

Equine Health Market Analysis 2024 and Forecasts 2032: Unveiling Growth Opportunities

Key Insights

The Equine Health Market size was valued at USD 1.84 USD Billion in 2023 and is projected to reach USD 2.90 USD Billion by 2032, exhibiting a CAGR of 6.7 % during the forecast period. Equine health is a concept related to having all-around healthy, emotionally stable, and high-performing horses. Spanning nutrients, workouts, preventing disease, and veterinary care, this book speaks on multiple topics. The different health-related issues in horses range from muscular skeleton problems, respiratory disorders, infectious diseases, and teeth matters. Regular check-ups, treatment plans suitable to the breed, the correct eating regime, and the specific vaccination are the main components that lead to a healthy horse. The possible impacts of equine health principles in racehorses and sports quality horses, medical care and equine practices mare and stud management, and general all-horse care are ever more apparent. The healthiness of the horses is one of the most societally influential aspects since it is rather important for performance enrichment, longevity of life, and liveable conditions of the horses in the different arenas. 

Equine Health Market Research Report - Market Size, Growth & Forecast

Equine Health Trends

  • Growing prevalence of equine diseases, such as equine influenza, West Nile virus, and equine herpes virus
  • Increasing awareness of equine health and welfare
  • Rising demand for preventive and therapeutic products for horses
  • Technological advancements in equine healthcare, including the development of new vaccines and treatments

Driving Forces: What's Propelling the Equine Health Market

  • Increasing number of horses worldwide
  • Rising disposable income of horse owners
  • Government initiatives to improve equine health and welfare
  • Growing adoption of companion animals, including horses

Challenges and Restraints in Equine Health Market

  • High cost of equine healthcare
  • Lack of access to veterinary care in some regions
  • Regulatory hurdles in the development and approval of new equine health products
  • Emergence of counterfeit and substandard equine health products

Emerging Trends in Equine Health

  • Precision medicine, including personalized treatment plans for horses
  • Use of artificial intelligence (AI) and machine learning (ML) to improve diagnostic and treatment strategies
  • Development of novel vaccines and therapeutics for equine diseases

Growth Catalysts in Equine Health Industry

Equine Health Market Growth
  • Growing investment in research and development of equine health products
  • Strategic partnerships between pharmaceutical companies and equine health organizations
  • Increasing awareness of preventive health practices for horses

Market Segmentation: Equine Health Analysis

Product:

  • Drug Class: Anti-Infective, Anti-Inflammatory, Parasiticides, and Others
  • Vaccines: Inactivated, Live Attenuated, Recombinant, and Others
  • Supplemental Feed Additives

Disease Type:

  • West Nile Virus
  • Equine Rabies
  • Equine Influenza
  • Equine Herpes Virus
  • Potomac Horse Fever
  • Tetanus
  • Others

Distribution Channel:

  • Veterinary Hospitals And Clinics
  • Retail Pharmacies and Drug Stores
  • Others

Leading Players in the Equine Health Market

  • Zoetis Services LLC (U.S.) 
  • Ceva (France) 
  • Elanco (U.S.)
  • Boehringer Ingelheim International GmbH (Germany)
  • Vetoquinol (France)
  • Neogen Corporation (U.S.)
  • Virbac (France) 
  • Merck & Co., Inc. (U.S.) 
  • Norbrook (U.K.) 
  • Purina Animal Nutrition LLC. (U.S.) 
  • Kyoritsuseiyaku Corporation (Japan)
  • Equine Products UK Ltd. (U.K.)

Significant Developments in Equine Health Sector

  • June 2023: Zoetis Inc. partnered with The United States Pony Clubs, Inc. (USPC) to offer leading equine health products and provide the horses with the best possible care.
  • May 2023: Merck & Co., Inc. partnered with US Equestrian for advancement in animal health through innovative products and technologies.
  • April 2023: Covetous launched SmartImmune Mushroom from SmartPak, a first-of-its-kind equine supplement made from a powerful mushroom extract blend to improve horses’ natural defenses against foreign pathogens.
  • March 2023: Neogen Corporation announced that the U.S. Environmental Protection Agency (EPA) has approved additional claims for its Neogen Viroxide Super disinfectant. It specifies that the product kills viruses on hard, non-porous surfaces.
  • December 2022: FDA approved Zycosan (pentosan polysulfate sodium injection) for osteoarthritis in horses. It is the first injectable Pentosan for the disease.

Comprehensive Coverage Equine Health Market Report

The equine health market report provides a comprehensive analysis of the global market, covering:

  • Market size, growth, trends, and forecasts
  • Market segmentation by product, disease type, and distribution channel
  • Competitive landscape and key players
  • Industry developments and news
  • SWOT analysis
  • Porter's Five Forces analysis

Regional Insight

Equine Health Market Regional Share

The equine health market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. North America and Europe are the dominant regions due to the high prevalence of horses and well-developed equine healthcare systems.

DROCT

Drivers: Growing number of horses, rising disposable income, and increasing awareness of equine health. 

Restraints: High cost of equine healthcare and regulatory hurdles. 

Opportunities: Technological advancements and growing demand for preventive care. 

Challenges: Counterfeit and substandard products. 

Trends: Precision medicine, AI/ML, and novel vaccines and therapeutics.

 

Pricing Analysis

The pricing of equine health products depends on several factors, including the type of product, brand, dosage, and distribution channel. Vaccines are typically more expensive than drugs, and branded products are generally more expensive than generic products.

 

Equine Health Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2018-2032
Base Year 2023
Estimated Year 2024
Forecast Period2024-2032
Historical Period2018-2023
Growth RateCAGR of 6.7 % from 2018-2032
Segmentation
    • By Product
      • Drug Class
      • {Anti-Infective
      • Anti-Inflammatory
      • Parasiticides
      • Others}
      • Vaccines {Inactivated
      • Live Attenuated
      • Recombinant
      • Others}
      • Supplemental Feed Additives
    • By Disease Type
      • West Nile Virus
      • Equine Rabies
      • Equine Influenza
      • Equine Herpes Virus
      • Potomac Horse Fever
      • Tetanus
      • Others
    • By Distribution Channel
      • Veterinary Hospitals And Clinics
      • Retail Pharmacies
      • Drug Stores
      • Others
  • By Geography
    • By Product
      • Drug Class
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Scandinavia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • Southeast Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of the Middle East & Africa

Frequently Asked Questions

Table Of Content
  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1. Surge in Prevalence of Equine Diseases to Boost Market Growth
      • 3.3. Market Restrains
        • 3.3.1. Shortage of Equine Veterinarians and Vaccine Failure Events to Hinder Market Expansion
      • 3.4. Market Trends
        • 3.4.1. Transition Toward Intranasal Route from Conventional Route of Administration to Propel Market Growth
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. Global Equine Health Market Analysis, Insights and Forecast, 2018-2030
    • 5.1. Market Analysis, Insights and Forecast - by Product
      • 5.1.1. Drug Class
      • 5.1.2. {Anti-Infective
      • 5.1.3. Anti-Inflammatory
      • 5.1.4. Parasiticides
      • 5.1.5. Others}
      • 5.1.6. Vaccines {Inactivated
      • 5.1.7. Live Attenuated
      • 5.1.8. Recombinant
      • 5.1.9. Others}
      • 5.1.10. Supplemental Feed Additives
    • 5.2. Market Analysis, Insights and Forecast - by Disease Type
      • 5.2.1. West Nile Virus
      • 5.2.2. Equine Rabies
      • 5.2.3. Equine Influenza
      • 5.2.4. Equine Herpes Virus
      • 5.2.5. Potomac Horse Fever
      • 5.2.6. Tetanus
      • 5.2.7. Others
    • 5.3. Market Analysis, Insights and Forecast - by Distribution Channel
      • 5.3.1. Veterinary Hospitals And Clinics
      • 5.3.2. Retail Pharmacies
      • 5.3.3. Drug Stores
      • 5.3.4. Others
    • 5.4. Market Analysis, Insights and Forecast - by Region
      • 5.4.1. By Product
      • 5.4.2. Europe
      • 5.4.3. Asia Pacific
      • 5.4.4. Latin America
      • 5.4.5. Middle East & Africa
  6. 6. By Product Equine Health Market Analysis, Insights and Forecast, 2018-2030
    • 6.1. Market Analysis, Insights and Forecast - by Product
      • 6.1.1. Drug Class
      • 6.1.2. {Anti-Infective
      • 6.1.3. Anti-Inflammatory
      • 6.1.4. Parasiticides
      • 6.1.5. Others}
      • 6.1.6. Vaccines {Inactivated
      • 6.1.7. Live Attenuated
      • 6.1.8. Recombinant
      • 6.1.9. Others}
      • 6.1.10. Supplemental Feed Additives
    • 6.2. Market Analysis, Insights and Forecast - by Disease Type
      • 6.2.1. West Nile Virus
      • 6.2.2. Equine Rabies
      • 6.2.3. Equine Influenza
      • 6.2.4. Equine Herpes Virus
      • 6.2.5. Potomac Horse Fever
      • 6.2.6. Tetanus
      • 6.2.7. Others
    • 6.3. Market Analysis, Insights and Forecast - by Distribution Channel
      • 6.3.1. Veterinary Hospitals And Clinics
      • 6.3.2. Retail Pharmacies
      • 6.3.3. Drug Stores
      • 6.3.4. Others
  7. 7. Europe Equine Health Market Analysis, Insights and Forecast, 2018-2030
    • 7.1. Market Analysis, Insights and Forecast - by Product
      • 7.1.1. Drug Class
      • 7.1.2. {Anti-Infective
      • 7.1.3. Anti-Inflammatory
      • 7.1.4. Parasiticides
      • 7.1.5. Others}
      • 7.1.6. Vaccines {Inactivated
      • 7.1.7. Live Attenuated
      • 7.1.8. Recombinant
      • 7.1.9. Others}
      • 7.1.10. Supplemental Feed Additives
    • 7.2. Market Analysis, Insights and Forecast - by Disease Type
      • 7.2.1. West Nile Virus
      • 7.2.2. Equine Rabies
      • 7.2.3. Equine Influenza
      • 7.2.4. Equine Herpes Virus
      • 7.2.5. Potomac Horse Fever
      • 7.2.6. Tetanus
      • 7.2.7. Others
    • 7.3. Market Analysis, Insights and Forecast - by Distribution Channel
      • 7.3.1. Veterinary Hospitals And Clinics
      • 7.3.2. Retail Pharmacies
      • 7.3.3. Drug Stores
      • 7.3.4. Others
  8. 8. Asia Pacific Equine Health Market Analysis, Insights and Forecast, 2018-2030
    • 8.1. Market Analysis, Insights and Forecast - by Product
      • 8.1.1. Drug Class
      • 8.1.2. {Anti-Infective
      • 8.1.3. Anti-Inflammatory
      • 8.1.4. Parasiticides
      • 8.1.5. Others}
      • 8.1.6. Vaccines {Inactivated
      • 8.1.7. Live Attenuated
      • 8.1.8. Recombinant
      • 8.1.9. Others}
      • 8.1.10. Supplemental Feed Additives
    • 8.2. Market Analysis, Insights and Forecast - by Disease Type
      • 8.2.1. West Nile Virus
      • 8.2.2. Equine Rabies
      • 8.2.3. Equine Influenza
      • 8.2.4. Equine Herpes Virus
      • 8.2.5. Potomac Horse Fever
      • 8.2.6. Tetanus
      • 8.2.7. Others
    • 8.3. Market Analysis, Insights and Forecast - by Distribution Channel
      • 8.3.1. Veterinary Hospitals And Clinics
      • 8.3.2. Retail Pharmacies
      • 8.3.3. Drug Stores
      • 8.3.4. Others
  9. 9. Latin America Equine Health Market Analysis, Insights and Forecast, 2018-2030
    • 9.1. Market Analysis, Insights and Forecast - by Product
      • 9.1.1. Drug Class
      • 9.1.2. {Anti-Infective
      • 9.1.3. Anti-Inflammatory
      • 9.1.4. Parasiticides
      • 9.1.5. Others}
      • 9.1.6. Vaccines {Inactivated
      • 9.1.7. Live Attenuated
      • 9.1.8. Recombinant
      • 9.1.9. Others}
      • 9.1.10. Supplemental Feed Additives
    • 9.2. Market Analysis, Insights and Forecast - by Disease Type
      • 9.2.1. West Nile Virus
      • 9.2.2. Equine Rabies
      • 9.2.3. Equine Influenza
      • 9.2.4. Equine Herpes Virus
      • 9.2.5. Potomac Horse Fever
      • 9.2.6. Tetanus
      • 9.2.7. Others
    • 9.3. Market Analysis, Insights and Forecast - by Distribution Channel
      • 9.3.1. Veterinary Hospitals And Clinics
      • 9.3.2. Retail Pharmacies
      • 9.3.3. Drug Stores
      • 9.3.4. Others
  10. 10. Middle East & Africa Equine Health Market Analysis, Insights and Forecast, 2018-2030
    • 10.1. Market Analysis, Insights and Forecast - by Product
      • 10.1.1. Drug Class
      • 10.1.2. {Anti-Infective
      • 10.1.3. Anti-Inflammatory
      • 10.1.4. Parasiticides
      • 10.1.5. Others}
      • 10.1.6. Vaccines {Inactivated
      • 10.1.7. Live Attenuated
      • 10.1.8. Recombinant
      • 10.1.9. Others}
      • 10.1.10. Supplemental Feed Additives
    • 10.2. Market Analysis, Insights and Forecast - by Disease Type
      • 10.2.1. West Nile Virus
      • 10.2.2. Equine Rabies
      • 10.2.3. Equine Influenza
      • 10.2.4. Equine Herpes Virus
      • 10.2.5. Potomac Horse Fever
      • 10.2.6. Tetanus
      • 10.2.7. Others
    • 10.3. Market Analysis, Insights and Forecast - by Distribution Channel
      • 10.3.1. Veterinary Hospitals And Clinics
      • 10.3.2. Retail Pharmacies
      • 10.3.3. Drug Stores
      • 10.3.4. Others
  11. 11. North America Equine Health Market Analysis, Insights and Forecast, 2018-2030
      • 11.1. Market Analysis, Insights and Forecast - By Product
        • 11.1.1 Drug Class
        • 11.1.2 {Anti-Infective
        • 11.1.3 Anti-Inflammatory
        • 11.1.4 Parasiticides
        • 11.1.5 and Others}
        • 11.1.6 Vaccines {Inactivated
        • 11.1.7 Live Attenuated
        • 11.1.8 Recombinant
        • 11.1.9 and Others}
        • 11.1.10 and Supplemental Feed Additives
      • 11.2. Market Analysis, Insights and Forecast - By Disease Type
        • 11.2.1 West Nile Virus
        • 11.2.2 Equine Rabies
        • 11.2.3 Equine Influenza
        • 11.2.4 Equine Herpes Virus
        • 11.2.5 Potomac Horse Fever
        • 11.2.6 Tetanus
        • 11.2.7 and Others
      • 11.3. Market Analysis, Insights and Forecast - By Distribution Channel
        • 11.3.1 Veterinary Hospitals And Clinics
        • 11.3.2 Retail Pharmacies and Drug Stores
        • 11.3.3 and Others
      • 11.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 11.4.1 United States
        • 11.4.2 Canada
        • 11.4.3 Mexico
  12. 12. South America Equine Health Market Analysis, Insights and Forecast, 2018-2030
      • 12.1. Market Analysis, Insights and Forecast - By Product
        • 12.1.1 Drug Class
        • 12.1.2 {Anti-Infective
        • 12.1.3 Anti-Inflammatory
        • 12.1.4 Parasiticides
        • 12.1.5 and Others}
        • 12.1.6 Vaccines {Inactivated
        • 12.1.7 Live Attenuated
        • 12.1.8 Recombinant
        • 12.1.9 and Others}
        • 12.1.10 and Supplemental Feed Additives
      • 12.2. Market Analysis, Insights and Forecast - By Disease Type
        • 12.2.1 West Nile Virus
        • 12.2.2 Equine Rabies
        • 12.2.3 Equine Influenza
        • 12.2.4 Equine Herpes Virus
        • 12.2.5 Potomac Horse Fever
        • 12.2.6 Tetanus
        • 12.2.7 and Others
      • 12.3. Market Analysis, Insights and Forecast - By Distribution Channel
        • 12.3.1 Veterinary Hospitals And Clinics
        • 12.3.2 Retail Pharmacies and Drug Stores
        • 12.3.3 and Others
      • 12.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 12.4.1 Brazil
        • 12.4.2 Argentina
        • 12.4.3 Rest of South America
  13. 13. Europe Equine Health Market Analysis, Insights and Forecast, 2018-2030
      • 13.1. Market Analysis, Insights and Forecast - By Product
        • 13.1.1 Drug Class
        • 13.1.2 {Anti-Infective
        • 13.1.3 Anti-Inflammatory
        • 13.1.4 Parasiticides
        • 13.1.5 and Others}
        • 13.1.6 Vaccines {Inactivated
        • 13.1.7 Live Attenuated
        • 13.1.8 Recombinant
        • 13.1.9 and Others}
        • 13.1.10 and Supplemental Feed Additives
      • 13.2. Market Analysis, Insights and Forecast - By Disease Type
        • 13.2.1 West Nile Virus
        • 13.2.2 Equine Rabies
        • 13.2.3 Equine Influenza
        • 13.2.4 Equine Herpes Virus
        • 13.2.5 Potomac Horse Fever
        • 13.2.6 Tetanus
        • 13.2.7 and Others
      • 13.3. Market Analysis, Insights and Forecast - By Distribution Channel
        • 13.3.1 Veterinary Hospitals And Clinics
        • 13.3.2 Retail Pharmacies and Drug Stores
        • 13.3.3 and Others
      • 13.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 13.4.1 Germany
        • 13.4.2 France
        • 13.4.3 Italy
        • 13.4.4 United Kingdom
        • 13.4.5 Netherlands
        • 13.4.6 Rest of Europe
  14. 14. Europe Equine Health Market Analysis, Insights and Forecast, 2018-2030
      • 14.1. Market Analysis, Insights and Forecast - By Product
        • 14.1.1 Drug Class
        • 14.1.2 {Anti-Infective
        • 14.1.3 Anti-Inflammatory
        • 14.1.4 Parasiticides
        • 14.1.5 and Others}
        • 14.1.6 Vaccines {Inactivated
        • 14.1.7 Live Attenuated
        • 14.1.8 Recombinant
        • 14.1.9 and Others}
        • 14.1.10 and Supplemental Feed Additives
      • 14.2. Market Analysis, Insights and Forecast - By Disease Type
        • 14.2.1 West Nile Virus
        • 14.2.2 Equine Rabies
        • 14.2.3 Equine Influenza
        • 14.2.4 Equine Herpes Virus
        • 14.2.5 Potomac Horse Fever
        • 14.2.6 Tetanus
        • 14.2.7 and Others
      • 14.3. Market Analysis, Insights and Forecast - By Distribution Channel
        • 14.3.1 Veterinary Hospitals And Clinics
        • 14.3.2 Retail Pharmacies and Drug Stores
        • 14.3.3 and Others
      • 14.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 14.4.1 Germany
        • 14.4.2 France
        • 14.4.3 Italy
        • 14.4.4 United Kingdom
        • 14.4.5 Netherlands
        • 14.4.6 Rest of Europe
  15. 15. MEA Equine Health Market Analysis, Insights and Forecast, 2018-2030
      • 15.1. Market Analysis, Insights and Forecast - By Product
        • 15.1.1 Drug Class
        • 15.1.2 {Anti-Infective
        • 15.1.3 Anti-Inflammatory
        • 15.1.4 Parasiticides
        • 15.1.5 and Others}
        • 15.1.6 Vaccines {Inactivated
        • 15.1.7 Live Attenuated
        • 15.1.8 Recombinant
        • 15.1.9 and Others}
        • 15.1.10 and Supplemental Feed Additives
      • 15.2. Market Analysis, Insights and Forecast - By Disease Type
        • 15.2.1 West Nile Virus
        • 15.2.2 Equine Rabies
        • 15.2.3 Equine Influenza
        • 15.2.4 Equine Herpes Virus
        • 15.2.5 Potomac Horse Fever
        • 15.2.6 Tetanus
        • 15.2.7 and Others
      • 15.3. Market Analysis, Insights and Forecast - By Distribution Channel
        • 15.3.1 Veterinary Hospitals And Clinics
        • 15.3.2 Retail Pharmacies and Drug Stores
        • 15.3.3 and Others
      • 15.4. Market Analysis, Insights and Forecast - By Country/Sub-region
        • 15.4.1 Middle East
        • 15.4.2 Africa
  16. 16. Competitive Analysis
    • 16.1. Global Market Share Analysis 2023
      • 16.2. Company Profiles
        • 16.2.1 Zoetis Services LLC (U.S.)
          • 16.2.1.1. Overview
          • 16.2.1.2. Products
          • 16.2.1.3. SWOT Analysis
          • 16.2.1.4. Recent Developments
          • 16.2.1.5. Financials (Based on Availability)
        • 16.2.2 Ceva (France)
          • 16.2.2.1. Overview
          • 16.2.2.2. Products
          • 16.2.2.3. SWOT Analysis
          • 16.2.2.4. Recent Developments
          • 16.2.2.5. Financials (Based on Availability)
        • 16.2.3 Elanco (U.S.)
          • 16.2.3.1. Overview
          • 16.2.3.2. Products
          • 16.2.3.3. SWOT Analysis
          • 16.2.3.4. Recent Developments
          • 16.2.3.5. Financials (Based on Availability)
        • 16.2.4 Boehringer Ingelheim International GmbH (Germany)
          • 16.2.4.1. Overview
          • 16.2.4.2. Products
          • 16.2.4.3. SWOT Analysis
          • 16.2.4.4. Recent Developments
          • 16.2.4.5. Financials (Based on Availability)
        • 16.2.5 Vetoquinol (France)
          • 16.2.5.1. Overview
          • 16.2.5.2. Products
          • 16.2.5.3. SWOT Analysis
          • 16.2.5.4. Recent Developments
          • 16.2.5.5. Financials (Based on Availability)
        • 16.2.6 Neogen Corporation (U.S.)
          • 16.2.6.1. Overview
          • 16.2.6.2. Products
          • 16.2.6.3. SWOT Analysis
          • 16.2.6.4. Recent Developments
          • 16.2.6.5. Financials (Based on Availability)
        • 16.2.7 Virbac (France)
          • 16.2.7.1. Overview
          • 16.2.7.2. Products
          • 16.2.7.3. SWOT Analysis
          • 16.2.7.4. Recent Developments
          • 16.2.7.5. Financials (Based on Availability)
        • 16.2.8 Merck & Co. Inc. (U.S.)
          • 16.2.8.1. Overview
          • 16.2.8.2. Products
          • 16.2.8.3. SWOT Analysis
          • 16.2.8.4. Recent Developments
          • 16.2.8.5. Financials (Based on Availability)
        • 16.2.9 Norbrook (U.K.)
          • 16.2.9.1. Overview
          • 16.2.9.2. Products
          • 16.2.9.3. SWOT Analysis
          • 16.2.9.4. Recent Developments
          • 16.2.9.5. Financials (Based on Availability)
        • 16.2.10 Purina Animal Nutrition LLC. (U.S.)
          • 16.2.10.1. Overview
          • 16.2.10.2. Products
          • 16.2.10.3. SWOT Analysis
          • 16.2.10.4. Recent Developments
          • 16.2.10.5. Financials (Based on Availability)
        • 16.2.11 Kyoritsuseiyaku Corporation (Japan)
          • 16.2.11.1. Overview
          • 16.2.11.2. Products
          • 16.2.11.3. SWOT Analysis
          • 16.2.11.4. Recent Developments
          • 16.2.11.5. Financials (Based on Availability)
        • 16.2.12 Equine Products UK Ltd. (U.K.)
          • 16.2.12.1. Overview
          • 16.2.12.2. Products
          • 16.2.12.3. SWOT Analysis
          • 16.2.12.4. Recent Developments
          • 16.2.12.5. Financials (Based on Availability)
List of Figures
  1. Figure 1: Global Equine Health Market Revenue Breakdown (USD Billion, %) by Region 2023 & 2031
  2. Figure 2: Global Equine Health Market Revenue (USD Billion), by Product 2023 & 2031
  3. Figure 3: Global Equine Health Market Revenue Share (%), by Product 2023 & 2031
  4. Figure 4: Global Equine Health Market Forecast (USD Billion), by Drug Class 2020 & 2031
  5. Figure 5: Global Equine Health Market Forecast (USD Billion), by {Anti-Infective 2020 & 2031
  6. Figure 6: Global Equine Health Market Forecast (USD Billion), by Anti-Inflammatory 2020 & 2031
  7. Figure 7: Global Equine Health Market Forecast (USD Billion), by Parasiticides 2020 & 2031
  8. Figure 8: Global Equine Health Market Forecast (USD Billion), by Others} 2020 & 2031
  9. Figure 9: Global Equine Health Market Forecast (USD Billion), by Vaccines {Inactivated 2020 & 2031
  10. Figure 10: Global Equine Health Market Forecast (USD Billion), by Live Attenuated 2020 & 2031
  11. Figure 11: Global Equine Health Market Forecast (USD Billion), by Recombinant 2020 & 2031
  12. Figure 12: Global Equine Health Market Forecast (USD Billion), by Others} 2020 & 2031
  13. Figure 13: Global Equine Health Market Forecast (USD Billion), by Supplemental Feed Additives 2020 & 2031
  14. Figure 14: Global Equine Health Market Revenue (USD Billion), by Disease Type 2023 & 2031
  15. Figure 15: Global Equine Health Market Revenue Share (%), by Disease Type 2023 & 2031
  16. Figure 16: Global Equine Health Market Forecast (USD Billion), by West Nile Virus 2020 & 2031
  17. Figure 17: Global Equine Health Market Forecast (USD Billion), by Equine Rabies 2020 & 2031
  18. Figure 18: Global Equine Health Market Forecast (USD Billion), by Equine Influenza 2020 & 2031
  19. Figure 19: Global Equine Health Market Forecast (USD Billion), by Equine Herpes Virus 2020 & 2031
  20. Figure 20: Global Equine Health Market Forecast (USD Billion), by Potomac Horse Fever 2020 & 2031
  21. Figure 21: Global Equine Health Market Forecast (USD Billion), by Tetanus 2020 & 2031
  22. Figure 22: Global Equine Health Market Forecast (USD Billion), by Others 2020 & 2031
  23. Figure 23: Global Equine Health Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  24. Figure 24: Global Equine Health Market Revenue Share (%), by Distribution Channel 2023 & 2031
  25. Figure 25: Global Equine Health Market Forecast (USD Billion), by Veterinary Hospitals And Clinics 2020 & 2031
  26. Figure 26: Global Equine Health Market Forecast (USD Billion), by Retail Pharmacies 2020 & 2031
  27. Figure 27: Global Equine Health Market Forecast (USD Billion), by Drug Stores 2020 & 2031
  28. Figure 28: Global Equine Health Market Forecast (USD Billion), by Others 2020 & 2031
  29. Figure 29: Global Equine Health Market Revenue (USD Billion), by Region 2023 & 2031
  30. Figure 30: Global Equine Health Market Revenue Share (%), by Region 2023 & 2031
  31. Figure 31: North America Equine Health Market Revenue (USD Billion), by Product 2023 & 2031
  32. Figure 32: North America Equine Health Market Revenue Share (%), by Product 2023 & 2031
  33. Figure 33: North America Equine Health Market Revenue (USD Billion), by Disease Type 2023 & 2031
  34. Figure 34: North America Equine Health Market Revenue Share (%), by Disease Type 2023 & 2031
  35. Figure 35: North America Equine Health Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  36. Figure 36: North America Equine Health Market Revenue Share (%), by Distribution Channel 2023 & 2031
  37. Figure 37: North America Equine Health Market Revenue (USD Billion), by Country 2023 & 2031
  38. Figure 38: North America Equine Health Market Revenue Share (%), by Country 2023 & 2031
  39. Figure 39: South America Equine Health Market Revenue (USD Billion), by Product 2023 & 2031
  40. Figure 40: South America Equine Health Market Revenue Share (%), by Product 2023 & 2031
  41. Figure 41: South America Equine Health Market Revenue (USD Billion), by Disease Type 2023 & 2031
  42. Figure 42: South America Equine Health Market Revenue Share (%), by Disease Type 2023 & 2031
  43. Figure 43: South America Equine Health Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  44. Figure 44: South America Equine Health Market Revenue Share (%), by Distribution Channel 2023 & 2031
  45. Figure 45: South America Equine Health Market Revenue (USD Billion), by Country 2023 & 2031
  46. Figure 46: South America Equine Health Market Revenue Share (%), by Country 2023 & 2031
  47. Figure 47: Europe Equine Health Market Revenue (USD Billion), by Product 2023 & 2031
  48. Figure 48: Europe Equine Health Market Revenue Share (%), by Product 2023 & 2031
  49. Figure 49: Europe Equine Health Market Revenue (USD Billion), by Disease Type 2023 & 2031
  50. Figure 50: Europe Equine Health Market Revenue Share (%), by Disease Type 2023 & 2031
  51. Figure 51: Europe Equine Health Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  52. Figure 52: Europe Equine Health Market Revenue Share (%), by Distribution Channel 2023 & 2031
  53. Figure 53: Europe Equine Health Market Revenue (USD Billion), by Country 2023 & 2031
  54. Figure 54: Europe Equine Health Market Revenue Share (%), by Country 2023 & 2031
  55. Figure 55: Europe Equine Health Market Revenue (USD Billion), by Product 2023 & 2031
  56. Figure 56: Europe Equine Health Market Revenue Share (%), by Product 2023 & 2031
  57. Figure 57: Europe Equine Health Market Revenue (USD Billion), by Disease Type 2023 & 2031
  58. Figure 58: Europe Equine Health Market Revenue Share (%), by Disease Type 2023 & 2031
  59. Figure 59: Europe Equine Health Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  60. Figure 60: Europe Equine Health Market Revenue Share (%), by Distribution Channel 2023 & 2031
  61. Figure 61: Europe Equine Health Market Revenue (USD Billion), by Country 2023 & 2031
  62. Figure 62: Europe Equine Health Market Revenue Share (%), by Country 2023 & 2031
  63. Figure 63: MEA Equine Health Market Revenue (USD Billion), by Product 2023 & 2031
  64. Figure 64: MEA Equine Health Market Revenue Share (%), by Product 2023 & 2031
  65. Figure 65: MEA Equine Health Market Revenue (USD Billion), by Disease Type 2023 & 2031
  66. Figure 66: MEA Equine Health Market Revenue Share (%), by Disease Type 2023 & 2031
  67. Figure 67: MEA Equine Health Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  68. Figure 68: MEA Equine Health Market Revenue Share (%), by Distribution Channel 2023 & 2031
  69. Figure 69: MEA Equine Health Market Revenue (USD Billion), by Country 2023 & 2031
  70. Figure 70: MEA Equine Health Market Revenue Share (%), by Country 2023 & 2031
  71. Figure 71: By Product Equine Health Market Revenue (USD Billion), by Product 2023 & 2031
  72. Figure 72: By Product Equine Health Market Revenue Share (%), by Product 2023 & 2031
  73. Figure 73: By Product Equine Health Market Revenue (USD Billion), by Disease Type 2023 & 2031
  74. Figure 74: By Product Equine Health Market Revenue Share (%), by Disease Type 2023 & 2031
  75. Figure 75: By Product Equine Health Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  76. Figure 76: By Product Equine Health Market Revenue Share (%), by Distribution Channel 2023 & 2031
  77. Figure 77: By Product Equine Health Market Revenue (USD Billion), by Country 2023 & 2031
  78. Figure 78: By Product Equine Health Market Revenue Share (%), by Country 2023 & 2031
  79. Figure 79: Europe Equine Health Market Revenue (USD Billion), by Product 2023 & 2031
  80. Figure 80: Europe Equine Health Market Revenue Share (%), by Product 2023 & 2031
  81. Figure 81: Europe Equine Health Market Revenue (USD Billion), by Disease Type 2023 & 2031
  82. Figure 82: Europe Equine Health Market Revenue Share (%), by Disease Type 2023 & 2031
  83. Figure 83: Europe Equine Health Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  84. Figure 84: Europe Equine Health Market Revenue Share (%), by Distribution Channel 2023 & 2031
  85. Figure 85: Europe Equine Health Market Revenue (USD Billion), by Country 2023 & 2031
  86. Figure 86: Europe Equine Health Market Revenue Share (%), by Country 2023 & 2031
  87. Figure 87: Asia Pacific Equine Health Market Revenue (USD Billion), by Product 2023 & 2031
  88. Figure 88: Asia Pacific Equine Health Market Revenue Share (%), by Product 2023 & 2031
  89. Figure 89: Asia Pacific Equine Health Market Revenue (USD Billion), by Disease Type 2023 & 2031
  90. Figure 90: Asia Pacific Equine Health Market Revenue Share (%), by Disease Type 2023 & 2031
  91. Figure 91: Asia Pacific Equine Health Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  92. Figure 92: Asia Pacific Equine Health Market Revenue Share (%), by Distribution Channel 2023 & 2031
  93. Figure 93: Asia Pacific Equine Health Market Revenue (USD Billion), by Country 2023 & 2031
  94. Figure 94: Asia Pacific Equine Health Market Revenue Share (%), by Country 2023 & 2031
  95. Figure 95: Latin America Equine Health Market Revenue (USD Billion), by Product 2023 & 2031
  96. Figure 96: Latin America Equine Health Market Revenue Share (%), by Product 2023 & 2031
  97. Figure 97: Latin America Equine Health Market Revenue (USD Billion), by Disease Type 2023 & 2031
  98. Figure 98: Latin America Equine Health Market Revenue Share (%), by Disease Type 2023 & 2031
  99. Figure 99: Latin America Equine Health Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  100. Figure 100: Latin America Equine Health Market Revenue Share (%), by Distribution Channel 2023 & 2031
  101. Figure 101: Latin America Equine Health Market Revenue (USD Billion), by Country 2023 & 2031
  102. Figure 102: Latin America Equine Health Market Revenue Share (%), by Country 2023 & 2031
  103. Figure 103: Middle East & Africa Equine Health Market Revenue (USD Billion), by Product 2023 & 2031
  104. Figure 104: Middle East & Africa Equine Health Market Revenue Share (%), by Product 2023 & 2031
  105. Figure 105: Middle East & Africa Equine Health Market Revenue (USD Billion), by Disease Type 2023 & 2031
  106. Figure 106: Middle East & Africa Equine Health Market Revenue Share (%), by Disease Type 2023 & 2031
  107. Figure 107: Middle East & Africa Equine Health Market Revenue (USD Billion), by Distribution Channel 2023 & 2031
  108. Figure 108: Middle East & Africa Equine Health Market Revenue Share (%), by Distribution Channel 2023 & 2031
  109. Figure 109: Middle East & Africa Equine Health Market Revenue (USD Billion), by Country 2023 & 2031
  110. Figure 110: Middle East & Africa Equine Health Market Revenue Share (%), by Country 2023 & 2031
List of Tables
  1. Table 1: Global Equine Health Market Revenue USD Billion Forecast, by Product 2018 & 2031
  2. Table 2: Global Equine Health Market Revenue USD Billion Forecast, by Disease Type 2018 & 2031
  3. Table 3: Global Equine Health Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  4. Table 4: Global Equine Health Market Revenue USD Billion Forecast, by Region 2018 & 2031
  5. Table 5: Global Equine Health Market Revenue USD Billion Forecast, by Product 2018 & 2031
  6. Table 6: Global Equine Health Market Revenue USD Billion Forecast, by Disease Type 2018 & 2031
  7. Table 7: Global Equine Health Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  8. Table 8: Global Equine Health Market Revenue USD Billion Forecast, by Region 2018 & 2031
  9. Table 9: Global Equine Health Market Revenue USD Billion Forecast, by Product 2018 & 2031
  10. Table 10: Global Equine Health Market Revenue USD Billion Forecast, by Disease Type 2018 & 2031
  11. Table 11: Global Equine Health Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  12. Table 12: Global Equine Health Market Revenue USD Billion Forecast, by Country 2018 & 2031
  13. Table 13: United States Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  14. Table 14: Canada Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  15. Table 15: Mexico Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  16. Table 16: Global Equine Health Market Revenue USD Billion Forecast, by Product 2018 & 2031
  17. Table 17: Global Equine Health Market Revenue USD Billion Forecast, by Disease Type 2018 & 2031
  18. Table 18: Global Equine Health Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  19. Table 19: Global Equine Health Market Revenue USD Billion Forecast, by Country 2018 & 2031
  20. Table 20: Brazil Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  21. Table 21: Argentina Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  22. Table 22: Rest of South America Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  23. Table 23: Global Equine Health Market Revenue USD Billion Forecast, by Product 2018 & 2031
  24. Table 24: Global Equine Health Market Revenue USD Billion Forecast, by Disease Type 2018 & 2031
  25. Table 25: Global Equine Health Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  26. Table 26: Global Equine Health Market Revenue USD Billion Forecast, by Country 2018 & 2031
  27. Table 27: Germany Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  28. Table 28: France Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  29. Table 29: Italy Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  30. Table 30: United Kingdom Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  31. Table 31: Netherlands Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  32. Table 32: Rest of Europe Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  33. Table 33: Global Equine Health Market Revenue USD Billion Forecast, by Product 2018 & 2031
  34. Table 34: Global Equine Health Market Revenue USD Billion Forecast, by Disease Type 2018 & 2031
  35. Table 35: Global Equine Health Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  36. Table 36: Global Equine Health Market Revenue USD Billion Forecast, by Country 2018 & 2031
  37. Table 37: Germany Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  38. Table 38: France Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  39. Table 39: Italy Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  40. Table 40: United Kingdom Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  41. Table 41: Netherlands Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  42. Table 42: Rest of Europe Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  43. Table 43: Global Equine Health Market Revenue USD Billion Forecast, by Product 2018 & 2031
  44. Table 44: Global Equine Health Market Revenue USD Billion Forecast, by Disease Type 2018 & 2031
  45. Table 45: Global Equine Health Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  46. Table 46: Global Equine Health Market Revenue USD Billion Forecast, by Country 2018 & 2031
  47. Table 47: Middle East Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  48. Table 48: Africa Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  49. Table 49: Global Equine Health Market Revenue USD Billion Forecast, by Product 2018 & 2031
  50. Table 50: Global Equine Health Market Revenue USD Billion Forecast, by Disease Type 2018 & 2031
  51. Table 51: Global Equine Health Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  52. Table 52: Global Equine Health Market Revenue USD Billion Forecast, by Country 2018 & 2031
  53. Table 53: Drug Class Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  54. Table 54: Global Equine Health Market Revenue USD Billion Forecast, by Product 2018 & 2031
  55. Table 55: Global Equine Health Market Revenue USD Billion Forecast, by Disease Type 2018 & 2031
  56. Table 56: Global Equine Health Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  57. Table 57: Global Equine Health Market Revenue USD Billion Forecast, by Country 2018 & 2031
  58. Table 58: Germany Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  59. Table 59: U.K. Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  60. Table 60: France Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  61. Table 61: Italy Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  62. Table 62: Spain Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  63. Table 63: Scandinavia Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  64. Table 64: Rest of Europe Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  65. Table 65: Global Equine Health Market Revenue USD Billion Forecast, by Product 2018 & 2031
  66. Table 66: Global Equine Health Market Revenue USD Billion Forecast, by Disease Type 2018 & 2031
  67. Table 67: Global Equine Health Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  68. Table 68: Global Equine Health Market Revenue USD Billion Forecast, by Country 2018 & 2031
  69. Table 69: China Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  70. Table 70: India Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  71. Table 71: Japan Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  72. Table 72: Australia Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  73. Table 73: Southeast Asia Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  74. Table 74: Rest of Asia Pacific Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  75. Table 75: Global Equine Health Market Revenue USD Billion Forecast, by Product 2018 & 2031
  76. Table 76: Global Equine Health Market Revenue USD Billion Forecast, by Disease Type 2018 & 2031
  77. Table 77: Global Equine Health Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  78. Table 78: Global Equine Health Market Revenue USD Billion Forecast, by Country 2018 & 2031
  79. Table 79: Brazil Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  80. Table 80: Mexico Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  81. Table 81: Rest of Latin America Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  82. Table 82: Global Equine Health Market Revenue USD Billion Forecast, by Product 2018 & 2031
  83. Table 83: Global Equine Health Market Revenue USD Billion Forecast, by Disease Type 2018 & 2031
  84. Table 84: Global Equine Health Market Revenue USD Billion Forecast, by Distribution Channel 2018 & 2031
  85. Table 85: Global Equine Health Market Revenue USD Billion Forecast, by Country 2018 & 2031
  86. Table 86: GCC Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  87. Table 87: South Africa Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
  88. Table 88: Rest of the Middle East & Africa Equine Health Market Revenue (USD Billion) Forecast, by Application 2018 & 2031
AspectsDetails
Study Period 2018-2032
Base Year 2023
Estimated Year 2024
Forecast Period2024-2032
Historical Period2018-2023
Growth RateCAGR of 6.7 % from 2018-2032
Segmentation
    • By Product
      • Drug Class
      • {Anti-Infective
      • Anti-Inflammatory
      • Parasiticides
      • Others}
      • Vaccines {Inactivated
      • Live Attenuated
      • Recombinant
      • Others}
      • Supplemental Feed Additives
    • By Disease Type
      • West Nile Virus
      • Equine Rabies
      • Equine Influenza
      • Equine Herpes Virus
      • Potomac Horse Fever
      • Tetanus
      • Others
    • By Distribution Channel
      • Veterinary Hospitals And Clinics
      • Retail Pharmacies
      • Drug Stores
      • Others
  • By Geography
    • By Product
      • Drug Class
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Scandinavia
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Australia
      • Southeast Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of the Middle East & Africa

STEP 1 - Identification of Relevant Samples Size from Population Database

Step Chart
bar chart
method chart

STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

approach chart
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.

Note* : In applicable scenarios

STEP 3 - Data Sources

Primary Research

  • Web Analytics
  • Survey Reports
  • Research Institute
  • Latest Research Reports
  • Opinion Leaders

Secondary Research

  • Annual Reports
  • White Paper
  • Latest Press Release
  • Industry Association
  • Paid Database
  • Investor Presentations
approach chart

STEP 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.
Get Free Sample
Hover animation image
 Pre Order Enquiry Request discount

Pricing

$4850
Single User License:
  • Only one user can access this report at time
  • users are not allowed to take a print out of the report PDF
$5850
Multi User License:
  • The report will be emailed to you in PDF format.
  • This is a multi-user license, allowing 1-10 employees within your organisation to access the report.
$6850
Corporate User License:
  • Sharable and Printable among all employees of your organization
  • Excel Raw data with access to full quantitative & financial market insights
  • Customization at no additional cost within the scope of the report
  • Graphs and Charts can be used during presentation
BUY NOW
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo
client logo

Tailored for you

  • In-depth Analysis Tailored to Specified Regions or Segments
  • Company Profiles Customized to User Preferences
  • Comprehensive Insights Focused on Specific Segments or Regions
  • Customized Evaluation of Competitive Landscape to Meet Your Needs
  • Tailored Customization to Address Other Specific Requirements
Ask for customization

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report

quotation
avatar

Jared Wan

Analyst at Providence Strategic Partners at Petaling Jaya

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

quotation
avatar

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

The response was good, and I got what I was looking for as far as the report. Thank you for that.

quotation
avatar

Erik Perison

US TPS Business Development Manager at Thermon

About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

+1 2017933837

+44 20 7097 9277

sales@marketresearchforecast.com

  • Home
  • About Us
  • Industries
    • Healthcare
    • Chemicals & Materials
    • Information & Technology
    • Machinery & Equipment
    • Energy & Power
    • Aerospace & Defense
    • Automotive & Transportation
    • Food & Beverages
    • Agriculture
    • Consumer Goods
    • Semiconductor & Electronics
    • Packaging
    • COVID-19 Analysis
  • Services
  • Contact
MRF logo
  • Home
  • About Us
  • Industries
    • Healthcare
    • Chemicals & Materials
    • Information & Technology
    • Machinery & Equipment
    • Energy & Power
    • Aerospace & Defense
    • Automotive & Transportation
    • Food & Beverages
    • Agriculture
    • Consumer Goods
    • Semiconductor & Electronics
    • Packaging
    • COVID-19 Analysis
  • Services
  • Contact
sales@marketresearchforecast.com

Business Address

Head Office

Office no. A 5010, fifth floor, Solitaire Business Hub, Near Phoenix mall, Pune, Maharashtra 411014

Contact Information

Craig Francis

Business Development Head

+1 940 441 3937

sales@marketresearchforecast.com

Extra Links

AboutContactsTestimonials
ServicesCareer

Subscribe

Get the latest updates and offers.

PackagingHealthcareAgricultureEnergy & PowerConsumer GoodsFood & BeveragesCOVID-19 AnalysisAerospace & DefenseChemicals & MaterialsMachinery & EquipmentInformation & TechnologyAutomotive & TransportationSemiconductor & Electronics

© 2024 AMA Research. All rights reserved

Privacy Policy
Terms and Conditions
FAQ

Related Reports

report thumbnailFemale Sexual Dysfunction Treatment Market

Female Sexual Dysfunction Treatment Market 2024 to Grow at 1...

report thumbnailUrinary Drainage Bags Market

Urinary Drainage Bags Market Analysis Report 2024: Market to...

report thumbnailGuidewires Market

Guidewires Market 2024 to Grow at 21.2 CAGR with XX USD mill...

report thumbnailAsia Pacific In-vitro Diagnostics Market

Asia Pacific In-vitro Diagnostics Market Analysis 2024 and F...

report thumbnailBrain Implants Market

Brain Implants Market Charting Growth Trajectories: Analysis...

report thumbnailContinuous Renal Replacement Therapy (CRRT) Market

Continuous Renal Replacement Therapy (CRRT) Market Future-pr...

report thumbnailFoot Prosthetics Market

Foot Prosthetics Market 2024 to Grow at 6.6 CAGR with 588.1 ...

report thumbnailImmunoglobulins Market

Immunoglobulins Market Decade Long Trends, Analysis and Fore...

report thumbnailNegative Pressure Wound Therapy (NPWT) Market

Negative Pressure Wound Therapy (NPWT) Market Is Set To Reac...

report thumbnailViral Vaccines Market

Viral Vaccines Market Unlocking Growth Opportunities: Analys...

report thumbnailNeurovascular Devices/Interventional Neurology Market

Neurovascular Devices/Interventional Neurology Market 2024 t...

report thumbnailU.S. Normal Saline for Parenteral Use Market

U.S. Normal Saline for Parenteral Use Market  Analysis Repor...

report thumbnailHealthcare Predictive Analytics Market

Healthcare Predictive Analytics Market Decade Long Trends, A...

report thumbnailStomach-Gastric- Cancer- Treatment Market

Stomach-Gastric- Cancer- Treatment Market Decade Long Trends...

report thumbnailBiomarkers Market

Biomarkers Market Report Probes the 38.41 USD billion Size, ...

report thumbnailAntiepileptic Drug Market

Antiepileptic Drug Market 2024-2032 Analysis: Trends, Compet...

report thumbnailSurgical Stapling Devices Market

Surgical Stapling Devices Market Insightful Analysis: Trends...

report thumbnailUrinary Catheter Market

Urinary Catheter Market Report Probes the 2.56 USD Billion S...

report thumbnailAdult Diapers Market

Adult Diapers Market Is Set To Reach 11.55 USD Billion By 20...

report thumbnailSpectacles Market

Spectacles Market 2024 to Grow at 5.7 CAGR with 91.56 USD bi...